PLx Pharma Winddown Corp.
PLx Pharma Winddown Corp., headquartered in the United States, operates within the pharmaceutical industry, focusing on the development of innovative drug delivery systems. Founded in 2013, the company has made significant strides in enhancing the safety and efficacy of medications, particularly through its proprietary technology that aims to reduce gastrointestinal side effects. The firm is best known for its unique formulations, which include products designed to improve the bioavailability of non-steroidal anti-inflammatory drugs (NSAIDs). PLx Pharma has established a notable market position, recognised for its commitment to advancing patient care through scientific innovation. As the company transitions into winddown, its legacy in the pharmaceutical sector remains impactful, reflecting a dedication to improving therapeutic outcomes.
DitchCarbon Score
How does PLx Pharma Winddown Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PLx Pharma Winddown Corp.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PLx Pharma Winddown Corp.'s reported carbon emissions
PLx Pharma Winddown Corp., headquartered in the US, currently does not have any available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may not have publicly disclosed its carbon footprint or climate commitments at this time. Without specific initiatives or targets outlined, it is unclear how PLx Pharma Winddown Corp. is addressing climate change or contributing to sustainability efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PLx Pharma Winddown Corp. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
